Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
Crossref DOI link: https://doi.org/10.1007/s00280-014-2551-4
Published Online: 2014-08-09
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Ji Soo
Jeung, Hei-Cheul
Rha, Sun Young
Ahn, Joong Bae
Kang, Beodeul
Chon, Hong Jae
Hong, Min Hee
Lim, Seungtaek
Yang, Woo Ick
Nam, Chung Mo
Chung, Hyun Cheol
Text and Data Mining valid from 2014-08-09